Gene · 3785
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a Ste20-like kinase-dependent signaling network orchestrating cytoskeletal and synaptic development of cortical neurons. | Cell Commun Signal | 2026 | 42827256 | PubTator, text mining | PubMed |
| Loose-patch recordings reveal differential Kv7-dependent effects on spontaneous excitatory activity in control and epileptic CA1. | Front Neurol | 2026 | 42798466 | PubTator, text mining | PubMed |
| Kv7 channels as pharmacological targets for central nervous system diseases. | Pharmacol Rev | 2026 | 42772203 | PubTator, text mining | PubMed |
| [Effectiveness and tolerability of ketogenic diet therapy in children with genetic developmental and epileptic encephalopathy onset within 2 years of age]. | Zhonghua Er Ke Za Zhi | 2026 | 42742013 | PubTator, text mining | PubMed |
| Discovery of Novel Bicyclic Pyrazole Amides as Potent Neuronal KV7 Potassium Channel Openers with Strong Preclinical Antiseizure Activity. | ACS Med Chem Lett | 2026 | 42741311 | PubTator, text mining | PubMed |
| [Electroclinical recognition of SCN2A, SCN8A, KCNQ2, and KCNQ3 pathogenic variants]. | Medicina (B Aires) | 2026 | 42659555 | PubTator, text mining | PubMed |
Targeted Sequencing and Haplotype Analysis of Voltage-Gated Potassium Channel Genes Reveal a Potential Association of KCNV2 Haplotypes with Antiseizure Medication Response in Turkish Patients with Epilepsy. | Pharmaceuticals (Basel) | 2026 | 42653690 | PubTator, text mining | PubMed |
| Genomic Sequencing in Neonatal Encephalopathy and Suspected Hypoxic-Ischaemic Encephalopathy: A Systematic Review. | Genes (Basel) | 2026 | 42650055 | PubTator, text mining | PubMed |
| Molecular Basis for Activation to Inhibition Switching in Kv7.2 Channel Modulators. | Angew Chem Int Ed Engl | 2026 | 42631357 | PubTator, text mining | PubMed |
| Development of a human iPSC and patient phenotyping resource for preclinical investigations of neurodevelopmental disorders. | Stem Cell Res | 2026 | 42612424 | PubTator, text mining | PubMed |
| An upstream open reading frame represses translation of the neuronal potassium channel KCNQ2. | Proc Natl Acad Sci U S A | 2026 | 42611988 | PubTator, text mining | PubMed |
| Early sodium channel blocker initiation is associated with better outcomes in KCNQ2 disorders. | Brain | 2026 | 42610455 | PubTator, text mining | PubMed |
| Early infantile developmental and epileptic encephalopathy: clinical spectrum, diagnosis, outcomes, and evolving treatment strategies. | Brain Dev | 2026 | 42607558 | PubTator, text mining | PubMed |
| Generation of induced pluripotent stem cell lines from a patient withKCNQ2-developmental and epileptic encephalopathy pathogenic variant c.783A > C; p.Phe261Leu, and a sibling control. | Stem Cell Res | 2026 | 42603519 | PubTator, text mining | PubMed |
| KCNQ2 Gain-of-Function Mutation Presenting as Respiratory Dysfunction and Non-epileptic Myoclonus. | Cureus | 2026 | 42591997 | PubTator, text mining | PubMed |
| Clinical Features and Gene Mutation of Neonatal Seizures. | J Clin Med | 2026 | 42452325 | PubTator, text mining | PubMed |
| Monogenic epilepsies exhibit distinct sleep endophenotypes. | medRxiv | 2026 | 42428076 | PubTator, text mining | PubMed |
| Exome sequencing of pashtun familial epilepsy in Pakistan reveals novel variants in LAMA5, KCNQ2 and GNAO1. | Mol Biol Rep | 2026 | 42313205 | PubTator, text mining | PubMed |
| Assessment of gabapentin efficacy in patients with KCNQ2-developmental epileptic encephalopathy. | Sci Rep | 2026 | 42286026 | PubTator, text mining | PubMed |
| Functional screen for subtype specificity of voltage sensor-targeted Kv7 potentiators. | Br J Pharmacol | 2026 | 42271185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3785/papers